Concepedia

Heather L. Palomino

HL

5

Publications

241

Citations

5

H-Index

2009

Active since

Affiliations

Johnson & Johnson (United States)(Current)

University of California San Diego

Heather L. Palomino is an author at Johnson & Johnson (United States) specializing in molecular pharmacology, pharmacology, and drug discovery.

Top concepts

Publications per year

2009–2015

5

Publications

5

Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter et al. · Molecular Pharmacology · 2011 · 72 citations

Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues

Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier et al. · ACS Medicinal Chemistry Letters · 2010 · 62 citations · Full text

, , +18

24-Hour Urine Phosphorus Excretion and Mortality and Cardiovascular Events

Heather L. Palomino, Dena E. Rifkin, Cheryl A.M. Anderson et al. · Clinical Journal of the American Society of Nephrology · 2013 · 50 citations · Full text

Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats

Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter et al. · British Journal of Pharmacology · 2015 · 43 citations · Full text

Characterization of a Robust Enzymatic Assay for Inhibitors of 2-Oxoglutarate-Dependent Hydroxylases

Kimon C. Kanelakis, Heather L. Palomino, Lina Li et al. · SLAS DISCOVERY · 2009 · 14 citations · Full text

Rows per page

1–5 of 5